Nuclivision
About Nuclivision
Nuclivision develops radiotracers and software solutions that enhance PET imaging workflows, improving image quality and reducing radiation exposure for oncology patients. The technology addresses long wait times and high costs associated with nuclear medicine, facilitating timely diagnosis and treatment.
<problem> Current PET imaging workflows often involve long wait times, high costs due to expensive radiotracer doses, and potential risks associated with radioactive exposure for oncology patients. These challenges can hinder timely diagnosis and treatment. </problem> <solution> Nuclivision offers software solutions designed to enhance PET imaging, focusing on improving image quality while reducing radiation exposure and optimizing workflows. Their flagship product, Nuclarity, leverages AI to deliver enhanced PET images, boosting patient safety and streamlining operations for more efficient imaging centers. By optimizing image acquisition and processing, Nuclarity assists physicians throughout the entire workflow, from initial scan to diagnosis and follow-up, ultimately tackling the challenges of growing demands, radioactive exposure, and high costs in nuclear medicine. </solution> <features> - AI-driven PET image enhancement to improve image quality - Reduction of radioactive tracer dose during scans - Streamlined workflows for more efficient imaging centers - Assistance for physicians throughout the entire imaging workflow, from acquisition to diagnosis and follow-up </features> <target_audience> The primary target audience includes physicians, nuclear medicine professionals, and hospitals seeking to improve PET imaging workflows, enhance patient safety, and reduce costs. </target_audience>
What does Nuclivision do?
Nuclivision develops radiotracers and software solutions that enhance PET imaging workflows, improving image quality and reducing radiation exposure for oncology patients. The technology addresses long wait times and high costs associated with nuclear medicine, facilitating timely diagnosis and treatment.
Where is Nuclivision located?
Nuclivision is based in Montrose-Ghent, Belgium.
When was Nuclivision founded?
Nuclivision was founded in 2022.
How much funding has Nuclivision raised?
Nuclivision has raised 430000.
- Location
- Montrose-Ghent, Belgium
- Founded
- 2022
- Funding
- 430000
- Employees
- 10 employees
- Major Investors
- Lumiares